Decreased MMP1 gene expression in acute myeloid leukaemia.
Acute myeloid leukaemia (AML) is a heterogeneous disorder of haematopoietic stem cells or progenitor cells. Metalloproteinases (MMPs) are proteolytic enzymes whose activity is increased in different types of solid tumours. These enzymes regulate many processes associated with tumour progression. In haematological malignancy, the role of MMPs seems to be underestimated, and only metalloproteinase 2 (MMP2) and metalloproteinase 9 (MMP9) have been widely examined so far. In this work, differences in metalloproteinase 1 (MMP1) gene expression between patients with AML and healthy individuals were assessed. The relative expression level of the MMP1 gene was obtained by a real time PCR method preceded by reverse transcription. The relative level of MMP1 gene expression in patients with AML was decreased when compared to that of the control group. The role of MMP1 in AML could be different from that in solid tumours. Decreased MMP1 gene expression in AML similar to that of MMP9, shows a greater role for MMP1 in normal haematopoiesis than in the development of leukaemic cells.
['Pietrzak|Jacek|J|http://orcid.org/0000-0002-9187-1199', 'Mirowski|Marek|M|', 'Jeleń|Agnieszka|A|', 'Świechowski|Rafał|R|', 'Wodziński|Damian|D|', 'Niebudek|Katarzyna|K|', 'Balcerczak|Ewa|E|']
D000328:Adult D000368:Aged D000369:Aged, 80 and over D005260:Female D015870:Gene Expression D015973:Gene Expression Regulation, Leukemic D006801:Humans D015470:Leukemia, Myeloid, Acute D008297:Male D020781:Matrix Metalloproteinase 1 D020782:Matrix Metalloproteinases D008875:Middle Aged D059467:Transcriptome
MMP1 MMP1 gene expression Acute myeloid leukaemia Real time PCR